NEW YORK (GenomeWeb News) – BGI-Shenzhen said today that it has completed its cash tender offer for Complete Genomics, setting the stage for the merger of the two firms to be finalized.

The offer, which has been delayed numerous times, expired at 11:59 EDT March 14. As of the expiration of the offer, the depositary for the offer indicated that 31.4 million shares, or 88 percent, of Complete's stock had been validly tendered and not withdrawn.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.